Biovail Sues Andrx Over Planned Cardizem Generic
Biovail, based in Barbados, sued Florida-based Andrx in Delaware district court. It asserted a patent that reshaped the hypertension drug niche in the mid-1990s.
Andrx completed an Abbreviated New Drug Application with the Food and Drug Administration, stating its intentions to create and market a generic version of Biovail’s Cardizem LA. Compelled by the Hatch-Waxman Act, Andrx informed Biovail of its...
To view the full article, register now.